CCL26 and chronic obstructive pulmonary disease: Following infection there were significant increases in eotaxin (P = .0002 and <.0001, Fig 4, B) and eotaxin-3 (P < .00001-.020, Fig 4, C) in the subjects with COPD but not in the controls without COPD (data not shown).